Changchun High-Tech Industry (Group) Co (SZSE:000661) ROE %: 3.57% (As of Jun. 2026) — 84% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000661 Changchun High-Tech Industry (Group) Co Ltd SZSE:000661
84 GF Score
Price ¥74.76
GF Value ¥85.96
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Changchun High-Tech Industry (Group) Co ROE %?

Changchun High-Tech Industry (Group) Co SZSE:000661 -1.54% 84 ROE % is 3.57% as of Jun. 2026, which is 84% below its 10-year median of 21.64. GuruFocus rates SZSE:000661 with a GF Score™ of 84/100 and a GF Value™ of ¥85.96 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 936 Drug Manufacturers companies, Changchun High-Tech Industry (Group) Co ranks worse than 69.44% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Changchun High-Tech Industry (Group) Co's annualized net income for the quarter that ended in Jun. 2026 was ¥798 Mil. Changchun High-Tech Industry (Group) Co's average Total Stockholders Equity over the quarter that ended in Jun. 2026 was ¥22,347 Mil. Therefore, Changchun High-Tech Industry (Group) Co's annualized ROE % for the quarter that ended in Jun. 2026 was 3.57%.

The historical rank and industry rank for Changchun High-Tech Industry (Group) Co's ROE % or its related term are showing as below:

SZSE:000661' s ROE % Range Over the Past 10 Years
Min: -1.57   Med: 21.64   Max: 32.04
Current: -1.57

During the past 13 years, Changchun High-Tech Industry (Group) Co's highest ROE % was 32.04%. The lowest was -1.57%. And the median was 21.64%.

SZSE:000661's ROE % is ranked worse than
69.44% of 936 companies
in the Drug Manufacturers industry
Industry Median: 6.135 vs SZSE:000661: -1.57

Changchun High-Tech Industry (Group) Co  (SZSE:000661) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2026 )
=Net Income/Total Stockholders Equity
=798.32/22346.9675
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(798.32 / 11821.812)*(11821.812 / 30719.7855)*(30719.7855 / 22346.9675)
=Net Margin %*Asset Turnover*Equity Multiplier
=6.75 %*0.3848*1.3747
=ROA %*Equity Multiplier
=2.6 %*1.3747
=3.57 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2026 )
=Net Income/Total Stockholders Equity
=798.32/22346.9675
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (798.32 / 804.112) * (804.112 / 1644.496) * (1644.496 / 11821.812) * (11821.812 / 30719.7855) * (30719.7855 / 22346.9675)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9928 * 0.489 * 13.91 % * 0.3848 * 1.3747
=3.57 %

Note: The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Changchun High-Tech Industry (Group) Co ROE % Related Terms


Changchun High-Tech Industry (Group) Co ROE % Historical Data

* Premium members only.

The historical data trend for Changchun High-Tech Industry (Group) Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Changchun High-Tech Industry (Group) Co ROE % Chart

Changchun High-Tech Industry (Group) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.46 25.38 22.59 11.46 0.69

Changchun High-Tech Industry (Group) Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.81 3.18 -17.95 4.98 3.57

SZSE:000661 vs ZTS: ROE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun High-Tech Industry (Group) Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changchun High-Tech Industry (Group) Co ROE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun High-Tech Industry (Group) Co's ROE % distribution charts can be found below:

* The bar in red indicates where Changchun High-Tech Industry (Group) Co's ROE % falls into.


SZSE:000661
84GF Score
Changchun High-Tech Industry (Group) Co Ltd SZSE:000661
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Changchun High-Tech Industry (Group) Co ROE % Calculation

Changchun High-Tech Industry (Group) Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=154.971/( (22999.515+22008.558)/ 2 )
=154.971/22504.0365
=0.69 %

Changchun High-Tech Industry (Group) Co's annualized ROE % for the quarter that ended in Jun. 2026 is calculated as

ROE %=Net Income (Q: Jun. 2026 )/( (Total Stockholders Equity (Q: Mar. 2026 )+Total Stockholders Equity (Q: Jun. 2026 ))/ count )
=798.32/( (22281.447+22412.488)/ 2 )
=798.32/22346.9675
=3.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 3.57% mean?
Changchun High-Tech Industry (Group) Co (SZSE:000661) has a ROE % of 3.57% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. This is 84% below median its historical median of 21.64. According to the industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #650 out of 936 companies in the Drug Manufacturers industry, placing it in the top 69.4%.
Is Changchun High-Tech Industry (Group) Co's ROE % too high?
Changchun High-Tech Industry (Group) Co's current ROE % of 3.57% is 84% below median its 10-year median of 21.64. The Drug Manufacturers industry median ROE % is 6.14. Changchun High-Tech Industry (Group) Co's value of 3.57% is 41.8% below this industry median. Based on the distribution chart, Changchun High-Tech Industry (Group) Co ranks #650 out of 936 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Changchun High-Tech Industry (Group) Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Changchun High-Tech Industry (Group) Co's ROE % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #650 out of 936 companies for ROE %. This places Changchun High-Tech Industry (Group) Co in the lower half of its industry. The industry median ROE % is 6.14. Changchun High-Tech Industry (Group) Co's value of 3.57% is 41.8% below this benchmark. While the company's 10-year median is 21.64 vs. the industry median of 6.14, Changchun High-Tech Industry (Group) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.14, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Changchun High-Tech Industry (Group) Co's current ROE % of 3.57% is 41.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changchun High-Tech Industry (Group) Co's current ROE % is 3.57%, which is 84% below median its own 10-year median of 21.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changchun High-Tech Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co (SZSE:000661) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥85.96, compared to a current price of ¥74.76 — trading 13% below its estimated fair value. The current ROE % is 3.57%, which is 84% below median its 10-year median of 21.64 and 41.8% below the Drug Manufacturers industry median of 6.14. Changchun High-Tech Industry (Group) Co's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Changchun High-Tech Industry (Group) Co (SZSE:000661), the current ROE % is 3.57% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Changchun High-Tech Industry (Group) Co (SZSE:000661) Overvalued in 2026?

Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co stock appears to be undervalued. The current stock price of ¥74.76 is trading 13% below its estimated GF Value™ of ¥85.96. GuruFocus considers Changchun High-Tech Industry (Group) Co to be Modestly Undervalued.

Key valuation signals for SZSE:000661:

  • ROE %: 3.57% (84% below median its 10-year median of 21.64)
  • GF Value™: ¥85.96 vs. price of ¥74.76 (13% below fair value)
  • GF Score™: 84/100 with 8 warning signs
  • Industry Position: 41.8% below the Drug Manufacturers median (#650 of 936)

No single metric tells the full story. See the SZSE:000661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Changchun High-Tech Industry (Group) Co Business Description

Address Intersection of Zhenyu Street and Dongweishan Road, 27th Floor, Building B, Hi-Tech Hairong Plaza, Jilin Province, Changchun, CHN, 130012
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
84GF Score

Get the complete analysis for SZSE:000661

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥74.76
Price
¥85.96
GF Value